Is anti-hepatitis B virus (HBV) immunization successful in elderly hemodialysis (HD) patients?

Clinical Nephrology

Volumn 58, Issue 4, 2002, Pages 301-304

  Jadoul, M ^a   Goubau, P ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

Elderly; Hemodialysis; Hepatitis B virus; Immunization; Vaccination

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; RECOMBINANT VACCINE;

ADULT; AGED; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEATH; DELTOID MUSCLE; DRUG EFFICACY; ENERGIX; GEOGRAPHIC DISTRIBUTION; GERIATRIC PATIENT; GROUPS BY AGE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEPATITIS B; HUMAN; KIDNEY FAILURE; MEDICAL DECISION MAKING; PREVALENCE; SEROCONVERSION; SERODIAGNOSIS; TREATMENT OUTCOME;

EID: 0036791712     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/cnp58301     Document Type: Article

References (19)

1. Benhamou E, Couroucé AM, Jungers P, Laplanche A, Degos F, Brangier J, Crosnier J 1984 Hepatitis B vaccine: randomized trial of immunogenicity in hemodialysis patients. Clin Nephrol 21: 143-147
2. Centers for Disease Control and Prevention 2001 Recommendations for preventing transmission of infections among chronic hemodialysis patients. MMWR 50: 1-41
3. Charest AF, McDougall J, Goldstein MB 2000 A randomized comparison of intradermal and intramuscular vaccination against hepatitis B virus in incident chronic hemodialysis patients. Am J Kidney Dis 36: 976-982
4. Crosnier J, Jungers P, Couroucé AM, Laplanche A, Benhamou E, Degos F, Lacour B, Prunet P, Cerisier Y, Guesry P 1981 Randomised placebo-controlled trial of hepatitis B surface antigen vaccine in French hemodialysis units: II, haemodialysis patients. Lancet I: 797-800
5. European Consensus Group on Hepatitis B Immunity 2000 Are booster immunizations needed for lifelong hepatitis B immunity? Lancet 355: 561-565
6. Fahrizi F, Martin P 2000 Hepatitis B virus infection in dialysis patients. Am J Nephrol 20: 1-11
7. Favero MS, Alter MJ 1996 The re-emergence of hepatitis B virus infection in hemodialysis centers. Semin Dial 9: 373-374
8. Ifudu O, Dawood M, Homel P, Friedman EA 1996 Excess morbidity in patients starting uremia therapy without prior care by a nephrologist. Am J Kidney Dis 28: 841-845
9. Köhler H, Arnold W, Renschin G, Dormeyer HH, Meyer zum Büschenfelde KH 1984 Active hepatitis B vaccination of dialysis patients and medical staff. Kidney Int 25: 124-128
10. Michel P, Janin G, El Yafi S, Chevallier P, Girard P, Laville M, Trepo C 1985 Improvement of immune response in dialysis patients to HEVAC B vaccine after multiple injections of vaccine. Proc EDTA-ERA 22: 1077-1082
11. Miller ER, Alter MJ, Tokars JI 1999 Protective effect of hepatitis B vaccine in chronic hemodialysis patients. Am J Kidney Dis 33: 356-360
12. Peces R, de la Torre M, Alcazar R, Urra JM 1997 Prospective analysis of the factors influencing the antibody response to hepatitis B vaccine in hemodialysis patients. Am J Kidney Dis 29: 239-245
13. Pirson Y, Alexandre GP, van Ypersele de Strihou C 1977 Long-term effect of HBs antigenemia on patient survival after renal transplantation. N Engl J Med 296: 194-196
14. Steketee R, Ziarnik ME, Davis JP 1988 Seroresponse to hepatitis B vaccine in patients and staft of renal dialysis centers, Wisconsin. Am J Epidemiol 127: 772-782
15. Stevens CE, Alter HJ, Taylor PE, Zang EA, Harley EJ, Szmuness W and the Dialysis Vaccine Trial Group 1984 Hepatitis B vaccine in patients receiving hemodialysis. Immunogenicity and efficacy. N Engl J Med 311: 496-501
16. St. Peter WL, Clark JL, Levos OM 1998 Drug therapy in haemodialysis patients. Drugs Aging 12: 441-459
17. USRDS 2000 A Summary of the United States ESRD Program. Am J Kidney Dis 36: S15-S36
18. van Geelen JA, Schalm SW, de Visser EM, Heijtink RA 1987 Immune response to hepatitis B vaccine in hemodialysis patients. Nephron 45: 216-218
19. Zuckerman JN, Zuckerman AJ, Symington I, Du W, Williams A, Dickson B, Young MD 2001 for the UK Hepacare Study Group. Evaluation of a new hepatitis B triple-antigen vaccine in inadequate responders to current vaccines. Hepatology 34: 798-802